Lepu Medical Technology (Beijing) Co., Ltd. (300003.SZ)
300003.SZ Stock Price Chart
Explore Lepu Medical Technology (Beijing) Co., Ltd. interactive price chart. Choose custom timeframes to analyze 300003.SZ price movements and trends.
300003.SZ Company Profile
Discover essential business fundamentals and corporate details for Lepu Medical Technology (Beijing) Co., Ltd. (300003.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
30 Oct 2009
Employees
8.81K
Website
https://en.lepumedical.comCEO
Fei Pu
Description
Lepu Medical Technology (Beijing) Co., Ltd. develops, produces, and sells medical devices and equipment. The company offers cardiovascular interventional products, such as coronary stents and balloons, catheters, guide wires, introducer sheaths, tourniquets, inflation devices, and PCI accessories; structural heart diseases products, including occluders, vascular plugs, delivery systems, and mechanical heart valves; cardiac rhythm management products, which include pacemakers, equipment, leads, and electrophysiology; off-pump coronary artery bypass grafting surgical cardiology products; and PTA balloons and guide wires peripheral interventional products. It also provides critical care products, such as vascular access products, needle free connectors, blood samplers, and pressure transducers; floor and suspended type digital subtraction angiography systems; in vitro diagnostic equipment and biomarkers; hemodialysis catheters and hollow fiber dialyzers; and general surgery products, including surgical staplers and endo surgery accessories. In addition, the company offers cardiovascular system drugs, such as antithrombotic, hypolipidemic, antihypertensive, antianginal, and heart failure treatment; ß-lactamase antibiotics and antifungal antimicrobial drugs; central nervous system drugs comprises painkillers and antidepressants; gastric/duodenal ulcer and chronic liver disease treatment drugs; respiratory system drugs; hypoproteinemia drugs; and activating blood circulation drugs. Further, it provides precision medicine, ECG telemonitoring, and cardiovascular disease consulting and management center services; medical S&T incubation and equity investment, and medical financial services; consultation, online pharmacy, and household medical equipment services; smart devices; and specialized hospital services for cardiovascular diseases, as well as involved in the co-construction of Cath lab. The company was founded in 1999 and is headquartered in Beijing, China.
300003.SZ Financial Timeline
Browse a chronological timeline of Lepu Medical Technology (Beijing) Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 17 Apr 2026
Upcoming earnings on 24 Oct 2025
Upcoming earnings on 22 Aug 2025
Revenue estimate is ¥1.47B.
Dividend declared on 20 Jun 2025
A dividend of ¥0.14 per share was announced, adjusted to ¥0.14. The dividend was paid on 20 Jun 2025.
Earnings released on 18 Apr 2025
EPS came in at -¥0.30 falling short of the estimated -¥0.07 by -328.57%, while revenue for the quarter reached ¥1.74B, beating expectations by +18.35%.
Earnings released on 28 Mar 2025
EPS came in at -¥0.30 falling short of the estimated ¥0.10 by -401.02%, while revenue for the quarter reached ¥1.32B, missing expectations by -27.53%.
Earnings released on 25 Oct 2024
EPS came in at ¥0.06 falling short of the estimated ¥0.17 by -64.71%, while revenue for the quarter reached ¥1.39B, missing expectations by -23.71%.
Dividend declared on 20 Sept 2024
A dividend of ¥0.14 per share was announced, adjusted to ¥0.14. The dividend was paid on 20 Sept 2024.
Earnings released on 24 Aug 2024
EPS came in at ¥0.12 falling short of the estimated ¥0.27 by -55.56%, while revenue for the quarter reached ¥1.44B, missing expectations by -36.74%.
Dividend declared on 27 Jun 2024
A dividend of ¥0.33 per share was announced, adjusted to ¥0.33. The dividend was paid on 27 Jun 2024.
Earnings released on 20 Apr 2024
EPS came in at -¥0.05 falling short of the estimated ¥0.20 by -125.00%, while revenue for the quarter reached ¥1.90B, missing expectations by -16.73%.
Earnings released on 30 Mar 2024
EPS came in at -¥0.05 falling short of the estimated ¥0.20 by -125.68%, while revenue for the quarter reached ¥1.69B, missing expectations by -35.78%.
Earnings released on 25 Oct 2023
EPS came in at ¥0.21 falling short of the estimated ¥0.37 by -43.24%, while revenue for the quarter reached ¥1.96B, missing expectations by -32.52%.
Earnings released on 25 Aug 2023
EPS came in at ¥0.20 falling short of the estimated ¥0.40 by -50.00%, while revenue for the quarter reached ¥1.86B, missing expectations by -41.33%.
Dividend declared on 30 Jun 2023
A dividend of ¥0.34 per share was announced, adjusted to ¥0.34. The dividend was paid on 30 Jun 2023.
Earnings released on 12 May 2023
EPS came in at ¥0.32 surpassing the estimated ¥0.29 by +10.34%, while revenue for the quarter reached ¥2.44B, missing expectations by -23.30%.
Earnings released on 25 Apr 2023
EPS came in at ¥0.32 surpassing the estimated ¥0.29 by +10.34%, while revenue for the quarter reached ¥2.85B, beating expectations by +39.94%.
Earnings released on 27 Oct 2022
EPS came in at ¥0.30 surpassing the estimated ¥0.29 by +3.45%, while revenue for the quarter reached ¥2.43B, missing expectations by -1.82%.
Earnings released on 26 Aug 2022
EPS came in at ¥0.40 falling short of the estimated ¥0.52 by -23.08%, while revenue for the quarter reached ¥2.78B, missing expectations by -30.22%.
Dividend declared on 30 Jun 2022
A dividend of ¥0.28 per share was announced, adjusted to ¥0.28. The dividend was paid on 30 Jun 2022.
Earnings released on 25 Apr 2022
EPS came in at ¥0.30 matching the estimated ¥0.30, while revenue for the quarter reached ¥2.03B, missing expectations by -20.56%.
Earnings released on 6 Apr 2022
EPS came in at ¥0.30 surpassing the estimated ¥0.16 by +89.37%, while revenue for the quarter reached ¥2.55B.
Earnings released on 28 Oct 2021
EPS came in at ¥0.11 falling short of the estimated ¥0.29 by -62.07%, while revenue for the quarter reached ¥2.11B, missing expectations by -62.07%.
Earnings released on 28 Aug 2021
EPS came in at ¥0.55 surpassing the estimated ¥0.32 by +71.88%, while revenue for the quarter reached ¥3.77B.
Dividend declared on 25 Jun 2021
A dividend of ¥0.23 per share was announced, adjusted to ¥0.23. The dividend was paid on 25 Jun 2021.
Earnings released on 27 Apr 2021
EPS came in at ¥0.41 surpassing the estimated ¥0.25 by +64.00%, while revenue for the quarter reached ¥2.75B.
Earnings released on 27 Feb 2021
EPS came in at -¥0.05 falling short of the estimated ¥0.07 by -171.43%, while revenue for the quarter reached ¥1.65B.
Earnings released on 28 Oct 2020
EPS came in at ¥0.47, while revenue for the quarter reached ¥2.15B.
Earnings released on 27 Aug 2020
EPS came in at ¥0.42, while revenue for the quarter reached ¥2.57B.
300003.SZ Stock Performance
Access detailed 300003.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.